Diabetic kidney disease: Risk factors, challenges and opportunities in the era of precision medicine

Sadav khan, S P Srinivas Nayak, Sudhanshu Sen, Durgesh Kumar, Vicky Kumar Verma, Dhruvi patel, G S Chakraborthy
{"title":"Diabetic kidney disease: Risk factors, challenges and opportunities in the era of precision medicine","authors":"Sadav khan, S P Srinivas Nayak, Sudhanshu Sen, Durgesh Kumar, Vicky Kumar Verma, Dhruvi patel, G S Chakraborthy","doi":"10.53771/ijbpsa.2023.5.2.0027","DOIUrl":null,"url":null,"abstract":"DKD is now recognized as the primary cause of chronic and end-stage-renal disease worldwide. The disease is characterized by changes in renal function and structure, followed by a gradual decline in kidney function, leading to ESRD. Risk factors for DKD include age, sex, race/ethnicity, family history of hyperglycemia and AKI. Recent studies have shown that certain medication classes, such as SGLT-2 inhibitors, can protect the kidneys independent of diabetes control. However, there are still gaps in our understanding of DKD, and its diagnosis is subjective due to the lack of a noninvasive biomarker. This makes it challenging to design clinical trials to identify effective treatments for the disease. Our review article aims to provide information on basic mechanisms of DKD, various treatment strategies and challenges by using personalized approaches to diagnosis and prevention.","PeriodicalId":400966,"journal":{"name":"International Journal of Biological and Pharmaceutical Sciences Archive","volume":"43 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Biological and Pharmaceutical Sciences Archive","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53771/ijbpsa.2023.5.2.0027","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

DKD is now recognized as the primary cause of chronic and end-stage-renal disease worldwide. The disease is characterized by changes in renal function and structure, followed by a gradual decline in kidney function, leading to ESRD. Risk factors for DKD include age, sex, race/ethnicity, family history of hyperglycemia and AKI. Recent studies have shown that certain medication classes, such as SGLT-2 inhibitors, can protect the kidneys independent of diabetes control. However, there are still gaps in our understanding of DKD, and its diagnosis is subjective due to the lack of a noninvasive biomarker. This makes it challenging to design clinical trials to identify effective treatments for the disease. Our review article aims to provide information on basic mechanisms of DKD, various treatment strategies and challenges by using personalized approaches to diagnosis and prevention.
糖尿病肾病:精准医疗时代的风险因素、挑战与机遇
DKD现在被认为是世界范围内慢性和终末期肾脏疾病的主要原因。该病的特点是肾脏功能和结构的改变,随后肾功能逐渐下降,导致ESRD。DKD的危险因素包括年龄、性别、种族/民族、高血糖家族史和AKI。最近的研究表明,某些药物,如SGLT-2抑制剂,可以独立于糖尿病控制保护肾脏。然而,我们对DKD的理解仍然存在差距,并且由于缺乏无创生物标志物,其诊断是主观的。这使得设计临床试验以确定该疾病的有效治疗方法具有挑战性。我们的综述文章旨在通过个性化的诊断和预防方法,提供DKD的基本机制,各种治疗策略和挑战的信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信